Toll-like receptor 4 polymorphisms and their haplotypes modulate the risk of developing diabetic retinopathy in type 2 diabetes patients

Molecular Vision

Volumn 20, Issue , 2014, Pages 704-713

  Singh, Kanhaiya ^a   Kant, Shri ^b   Singh, Vivek Kumar ^c   Agrawal, Neeraj K ^b   Gupta, Sanjeev K ^b   Singh, Kiran ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HAPLOTYPES; HUMANS; INDIA; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4;

EID: 84901623543     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Singh K, Agrawal NK, Gupta SK, Singh K. Association of Variant rs7903146 (C/T) Single nucleotide polymorphism of TCF7L2 gene with impairment in wound healing among north Indian Type 2 Diabetes population: A Case-Control Study. Int J Low Extrem Wounds 2013; 12:310-5. [PMID: 24214952].
2. Singh K, Agrawal NK, Gupta SK, Singh K. A Functional SNP-1562C>T in the Matrix Metalloproteinases-9 Promoter is associated with type 2 diabetes and Diabetic Foot Ulcers. Int J Low Extrem Wounds 2013; 12:199-204. [PMID: 24043671].
3. Kohener EM, Stratton IM, Aldinton SJ. Prevalence of diabetic retinopathy at diagnosis of NIDDM in the UKPDS. Invest Ophthalmol Vis Sci 1993; 34:713-.
4. Navarro JF, Mora C. Role of inflammation in diabetic complications. Nephrol Dial Transplant 2005; 20:2601-4. [PMID: 16188894].
5. Petrovic D. Candidate Genes for Proliferative Diabetic Retinopathy. BioMed Research International 2013;2013; 540416.
6. Abu El-Asrar AM, Struyf S, Opdenakker G, Damme JV, Geboes K. Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Mol Vis 2010; 16:1098-107. [PMID: 20596251].
7. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. Hereditary variation in platelet integrin α2β1 density is associated with two silent polymorphisms in the α2 gene coding sequence. Blood 1997; 89:1939-43. [PMID: 9058714].
8. McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 1995; 147:642-53. [PMID: 7545873].
9. Kanhaiya, Agrawal NK, Gupta SK, Singh K. Differential expression of Toll like Receptor 4 in Type 2 Diabetic patients with impaired wound healing. Journal of Diabetes and Metabolism 2013; 4:260-.
10. Singh K, Singh VK, Agrawal NK, Gupta SK, Singh K. Association of Toll-like receptor 4 polymorphisms with diabetic foot ulcers and application of artificial neural network in DFU risk assessment in type 2 diabetes patients. Biomed Res Int. 2013; 2013:318686-[PMID: 23936790].
11. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801. [PMID: 16497588].
12. Armant MA, Fenton MJ. Toll-like receptors: a family of pattern-recognition receptors inmammals. Genome Biol 2002; 3:3011-.
13. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptors mRNAs in leukocytes in response to microbes, their products and cytokines. J Immunol 2002; 168:554-61. [PMID: 11777946].
14. Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-80. [PMID: 11477402].
15. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, Andre F, Delaloge S, Tursz T, Kroemer G, Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050-9. [PMID: 17704786].
16. Prohinar P, Rallabhandi P, Weiss JP, Gioannini TL. Expression of functional D299G. T399I polymorphic variant of TLR4 depends more on co-expression of MD-2 than does wild-type TLR4. J Immunol 2010; 184:4362-7. [PMID: 20212095].
17. Song J, Kim DY, Kim CS, Kim HJ, Lee DH, Lee HM, Ko W, Lee G. The association between Toll-like receptor 4 (TLR4) polymorphisms and the risk of prostate cancer in Korean men. Cancer Genet Cytogenet 2009; 190:88-92. [PMID: 19380025].
18. Buraczynska M, Baranowicz-Gaszczyk I, Tarach J, Ksiazek A. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum Immunol 2009; 70:121-4. [PMID: 19135114].
19. Zareparsi S, Buraczynska M, Branham KE, Shah S, Eng D, Li M, Pawar H, Yashar BM, Moroi SE, Lichter PR, Petty HR, Richards JE, Abecasis GR, Elner VM, Swaroop A. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005; 14:1449-55. [PMID: 15829498].
20. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991; 98:806-96.
21. Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 2005; 11:567-75. [PMID: 15905704].
22. Leung TF, Tang NL, Wong GW, Fok TF. CD14 and Toll-like receptors: Potential contribution of genetic factors and mechanisms to inflammation and allergy. Curr Drug Targets Inflamm Allergy 2005; 4:169-75. [PMID: 15853738].
23. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, Iijima H, Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T, Nishida T, Inatani M, Tanihara H, Aihara M, Araie M, Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T, Kiuchi Y, Iwase A, Ohno S, Inoko H, Mizuki N. Association of Toll-like Receptor 4 Gene Polymorphisms with Normal Tension Glaucoma. Invest Ophthalmol Vis Sci 2008; 49:4453-7. [PMID: 18586872].
24. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:1-14. [PMID: 15585605].
25. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KE, Lissowska J, Zatonski W, Schoenberg JB, Blot WJ, Mowat NA, Fraumeni JF Jr, El-Omar EM. A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007; 132:905-12. [PMID: 17324405].
26. Achyut BR, Ghoshal UC, Moorchung N, Mittal B. Association of Toll-like receptor-4 (Asp299Gly and Thr399Ile) gene polymorphism with gastritis and precancerous lesions. Hum Immunol 2007; 68:901-7. [PMID: 18082569].
27. Ferronato S, Gomez-Lira M, Menegazzi M, Diani E, Olivato S, Sartori M, Scuro A, Malerba G, Pignatti PF, Romanelli MG, Mazzucco S. Polymorphism-2604G>A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients. J Hum Genet 2013; 58:812-4. [PMID: 24108365].
28. Suh W, Kim S. Ki Chang-Seok, Kee C. Toll-like Receptor 4 gene polymorphisms do not associate with normal tension glaucoma in a Korean population. Mol Vis 2011; 17:2343-8. [PMID: 21921986].
29. Rudofsky G Jr, Reismann P, Witte S, Humpert PM, Isermann B, Chavakis T, Tafel J, Nosikov VV, Hamann A, Nawroth P, Bierhaus A. Asp299Gly and Thr399Ile Genotypes of the TLR4 Gene Are Associated With a Reduced Prevalence of Diabetic Neuropathy in Patients with Type 2 Diabetes. Diabetes Care 2004; 27:179-83. [PMID: 14693986].